Atlas Trials

A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer

Clinical trial NCT04241276 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04241276
Sponsor
Queen Mary University of London
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2020-04-30
Primary completion
2028-06-29
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.